ATE57471T1 - Im blut identifiziertes protein, ein verfahren zu seiner zubereitung, ein verfahren fuer die bestimmung dieses proteins und ebenfalls des t-pa-hemmungsfaktors und pharmazeutische zusammensetzungen, die dieses protein enthalten. - Google Patents
Im blut identifiziertes protein, ein verfahren zu seiner zubereitung, ein verfahren fuer die bestimmung dieses proteins und ebenfalls des t-pa-hemmungsfaktors und pharmazeutische zusammensetzungen, die dieses protein enthalten.Info
- Publication number
- ATE57471T1 ATE57471T1 AT86201213T AT86201213T ATE57471T1 AT E57471 T1 ATE57471 T1 AT E57471T1 AT 86201213 T AT86201213 T AT 86201213T AT 86201213 T AT86201213 T AT 86201213T AT E57471 T1 ATE57471 T1 AT E57471T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- pharmaceutical compositions
- compositions containing
- relates
- blood
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
- C07K14/8132—Plasminogen activator inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8502017A NL8502017A (nl) | 1985-07-12 | 1985-07-12 | Nieuw, in het bloed geidentificeerd eiwit, werkwijze ter bereiding daarvan, werkwijze ter bepaling van dit eiwit en tevens van t-pa-remmer, en farmaceutische preparaten die het eiwit bevatten. |
EP86201213A EP0208383B1 (de) | 1985-07-12 | 1986-07-10 | Im Blut identifiziertes Protein, ein Verfahren zu seiner Zubereitung, ein Verfahren für die Bestimmung dieses Proteins und ebenfalls des t-PA-Hemmungsfaktors und pharmazeutische Zusammensetzungen, die dieses Protein enthalten |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE57471T1 true ATE57471T1 (de) | 1990-11-15 |
Family
ID=19846293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT86201213T ATE57471T1 (de) | 1985-07-12 | 1986-07-10 | Im blut identifiziertes protein, ein verfahren zu seiner zubereitung, ein verfahren fuer die bestimmung dieses proteins und ebenfalls des t-pa-hemmungsfaktors und pharmazeutische zusammensetzungen, die dieses protein enthalten. |
Country Status (6)
Country | Link |
---|---|
US (1) | US5004802A (de) |
EP (1) | EP0208383B1 (de) |
JP (1) | JP2512437B2 (de) |
AT (1) | ATE57471T1 (de) |
DE (1) | DE3674955D1 (de) |
NL (1) | NL8502017A (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5372719A (en) * | 1992-03-30 | 1994-12-13 | Perseptive Biosystems, Inc. | Molecular imaging |
US5474766A (en) * | 1992-12-18 | 1995-12-12 | Washington University | Methods and compositions for inhibition of hepatic clearance of tissue-type plasminogen activator |
US5607841A (en) * | 1994-06-20 | 1997-03-04 | Lipinski; Boguslaw | Preparation and proteolytic degradation of a macromolecular protein complex from fibrinogen |
US10160813B2 (en) | 2013-01-22 | 2018-12-25 | University Of Tennessee Research Foundation | Tissue plasminogen activator antibodies and methods of use |
-
1985
- 1985-07-12 NL NL8502017A patent/NL8502017A/nl not_active Application Discontinuation
-
1986
- 1986-07-10 EP EP86201213A patent/EP0208383B1/de not_active Expired - Lifetime
- 1986-07-10 AT AT86201213T patent/ATE57471T1/de not_active IP Right Cessation
- 1986-07-10 DE DE8686201213T patent/DE3674955D1/de not_active Expired - Fee Related
- 1986-07-11 US US06/884,418 patent/US5004802A/en not_active Expired - Fee Related
- 1986-07-12 JP JP61164544A patent/JP2512437B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2512437B2 (ja) | 1996-07-03 |
US5004802A (en) | 1991-04-02 |
DE3674955D1 (de) | 1990-11-22 |
JPS6277326A (ja) | 1987-04-09 |
NL8502017A (nl) | 1987-02-02 |
EP0208383A1 (de) | 1987-01-14 |
EP0208383B1 (de) | 1990-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Stricklin et al. | Human skin collagenase: isolation of precursor and active forms from both fibroblast and organ cultures | |
Content et al. | Secretory proteins induced in human fibroblasts under conditions used for the production of interferon beta. | |
Kagan et al. | Purification and properties of four species of lysyl oxidase from bovine aorta | |
Summaria et al. | Isolation and characterization of the affinity chromatography forms of human Glu-and Lys-plasminogens and plasmins. | |
BG60256B1 (bg) | Рекомбинантен метод за получаване на лимфотоксин | |
Silverstein et al. | Tissue plasminogen activator and urokinase enhance the binding of plasminogen to thrombospondin. | |
Kohno et al. | Kidney plasminogen activator: a precursor form of human urokinase with high fibrin affinity | |
Havell et al. | Altered molecular species of human interferon produced in the presence of inhibitors of glycosylation. | |
Deogny et al. | Improved fibrin plate method for fibrinolytic activity measurements: use of bentonite precipitation and agar solidification | |
ATE113960T1 (de) | Proteingewinnung. | |
Dahl et al. | Enhancement of urokinase-induced plasminogen activation by the cationic protein of human eosinophil granulocytes | |
Sia et al. | Studies on the subunit structure of rabbit liver fructose diphosphatase | |
Thorsen et al. | Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator | |
EP0256836A1 (de) | Verfahren zur Reinigung von TPA aus rohen Präparaten | |
Boyes et al. | Purification of an insulin‐sensitive cyclic AMP phosphodiesterase from rat liver | |
Kruithof et al. | Influence of detergents on the measurement of the fibrinolytic activity of plasminogen activators | |
ATE57471T1 (de) | Im blut identifiziertes protein, ein verfahren zu seiner zubereitung, ein verfahren fuer die bestimmung dieses proteins und ebenfalls des t-pa-hemmungsfaktors und pharmazeutische zusammensetzungen, die dieses protein enthalten. | |
Livingstone et al. | The purification and preliminary characterization of UMP synthase from human placenta. | |
Franklin et al. | Chromatographic evidence for the existence of multiple forms of cathepsin B1 | |
Wicher et al. | Interactions of Bacillus subtilis alkaline proteinases with α2-macroglobulin and α1-antitrypsin | |
Lundblad et al. | The covalent differences between bovine alpha-and beta-thrombin. A structural explanation for the changes in catalytic activity. | |
York et al. | Interaction of fragments of fibrinogen with insolubilized fibrin monomers (activated fibrinogen) | |
Robinson et al. | Trypsins In Human Pancreatic Juice–Their Distribution as Found in 34 Specimens. Two Human Pancreatic Trypsinogens | |
Gache et al. | Susceptibility of platelet α-actinin to a Ca2+-activated neutral protease | |
Markland et al. | Resolution of isoforms of natural and recombinant fibrinolytic snake venom enzyme using high performance capillary electrophoresis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |